The activation or overexpression of STAT1 could upregulate iNOS signaling pathways (Figure 3f) by promoting interferon regulatory factor 1 (IRF1) expression, resulting in the induction of inducible nitric oxide synthase (iNOS or NOS2), which, in turn, improved the effect of cisplatin on cancer cells [33]. This evidence concerns the gene IRF1 and cancer.